Most lately, it's been determined that conolidine and the above derivatives act to the atypical chemokine receptor three (ACKR3. Expressed in similar areas as classical opioid receptors, it binds into a big selection of endogenous opioids. As opposed to most opioid receptors, this receptor acts to be a scavenger and won't activate a second messenge